StataDx
Boston, US · Founded 2021 · Delaware corporation · 1 known investors
Find your way into StataDx
StataDx is developing a point-of-care diagnostic platform for neurology that measures multiple blood biomarkers (such as Neurofilament-light, pTau-217, GFAP, S100b, and UCH-L1) from a fingerprick whole blood sample. The system uses multiplexed cartridges with mobile and cloud connectivity for biomarker-guided disease management in clinics or at patients' homes.
Founders & leadership
DL
Daniel LookadooExecutive
SJ
Sidhant JenaExecutive
Board
DI
Donald IngberinCo-FounderScientific Founder, Board Member, Scientific Advisory Board Chairman at Emulatebio
AS
Amarpreet SawhneyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.4M disclosed across 3 rounds · 2022–2026
▶$1.9MraisedApr 2026 · 7 investors · Other Health CareRule 506(b)
▶$1.9MraisedApr 2026 · 7 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Daniel LookadooExecutive Officer
- Donald IngberDirector
- Amarpreet SawhneyDirector
- Sidhant JenaExecutive Officer, Director
- Offering amount
- $2.5M
- Amount sold
- $1.9M
- Proceeds to insiders
- $175K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.8MraisedMar 2024 · 5 investors · Other Health CareRule 506(b)
▶$1.8MraisedMar 2024 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Donald IngberDirector
- Amarpreet SawhneyDirector
- Sidhant JenaExecutive Officer, Director
- Michal DepaExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.8M
- Proceeds to insiders
- $200K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$2.7MraisedFeb 2022 · 5 investors · OtherRule 506(b)
▶$2.7MraisedFeb 2022 · 5 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Sidhant JenaExecutive Officer
- Offering amount
- $2.7M
- Amount sold
- $2.7M
- Minimum investment
- $100K
- Proceeds to insiders
- $400K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through StataDx went on to found or lead other companies.
Frequently asked questions
- What does StataDx do?
- StataDx is developing a point-of-care diagnostic platform for neurology that measures multiple blood biomarkers (such as Neurofilament-light, pTau-217, GFAP, S100b, and UCH-L1) from a fingerprick whole blood sample. The system uses multiplexed cartridges with mobile and cloud connectivity for biomarker-guided disease management in clinics or at patients' homes.
- Who are StataDx's investors?
- StataDx's investors include MassVentures.
- How much funding has StataDx raised?
- StataDx has disclosed $6.4M raised across 3 rounds.
- Where is StataDx headquartered?
- StataDx is headquartered in Boston, US.